Steven Lo, Vaxart CEO

Vaxart wins $453M in BAR­DA fund­ing for oral Covid-19 vac­cine

The Bio­med­ical Ad­vanced Re­search and De­vel­op­ment Au­thor­i­ty (BAR­DA) has grant­ed up to $453 mil­lion to Vaxart to re­vive its work on an oral Covid-19 vac­cine …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.